BioWorld

May 11, 2015

As IPO market wanes, biotechs turn to reverse mergers

Through the first four months of the year, BioWorld Snapshots tracked 24 IPOs by drug companies on U.S. and international exchanges compared to 36 in the same time period last year. Read More

Week in review

Word on the street

Week in Washington

Biotech money raised by month in 2015

Public financing of biotechnology companies: Commenced trading in April 2015

Public financing of biotechnology companies: Filed and pending IPOs

2015 top private financings of public companies

Other financings of public biotechnology companies: April 2015

2015 top financings of private companies

Venture capital & other investments in private biotechnology companies: April 2015

Milestone payments from corporate partners: April 2015

Money raised by biotech in 2015 vs. 2014

Money raised by biotech Jan. 1 - May 7, 2015

Nasdaq Stock Index 2015

BioWorld Stock Index 2015

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

BioWorld briefs for Feb. 11, 2025.

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...